Forus
Agent21 out of 100, Bottom 25%. Agent Readiness. Open the scores section.Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Trust62 out of 100, Above median. Data Trust. Open the scores section.Data Trust: 62/100. Above median. Measured by StartupHub.ai. Median 61.Accelerating medicine for the people who need it, prescribe it, and create it.
About
Forus automates the entire process from prescription to affordable medication access, enabling patients to start therapy faster. Their AI-powered platform handles prior authorizations, appeal letters, enrollment forms, pharmacy routing, and benefit verifications for all drugs, insurance, and pharmacies nationwide. Forus serves doctors and their staff by reclaiming clinical time spent on administrative tasks and providing real-time prescription tracking.
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Biotech
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Shares Biotechnology, Biotech
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Pharmaceuticals
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- forus.com
- Headquarters
- New York, NY, USA
- Founded
- 2021
- Total funding
- $310M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 8 Sept 2026 | Series C | $150M | $3.0B | |
| 12 May 2026 | Funding Round | $160M |
Tech stack
Detected on forus.com, last scanned 2 Nov 2026. Run your own scan
- CDN
- Vercel
- Email provider
- Google Workspace
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Forus trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Forus is 62 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Forus raised?
Forus has raised a total of $310M in funding. The most recent round on record is Series C.
SEC filings, insider activity, nonprofit links and pay benchmarks for Forus:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
